Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,609.45INR
11:26am BST
Change (% chg)

Rs-53.50 (-3.22%)
Prev Close
Rs1,662.95
Open
Rs1,690.00
Day's High
Rs1,694.00
Day's Low
Rs1,420.00
Volume
47,713
Avg. Vol
44,298
52-wk High
Rs1,800.05
52-wk Low
Rs1,010.00

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 8,215.00 8,215.00 8,215.00 --
Year Ending Mar-18 9 30,763.50 32,896.20 29,140.00 --
Year Ending Mar-19 9 33,152.40 37,704.90 31,873.00 36,326.00
Year Ending Mar-20 8 36,746.40 39,698.00 34,643.00 39,335.00
Earnings (per share)
Year Ending Mar-18 9 21.16 24.55 18.75 --
Year Ending Mar-19 9 26.57 30.65 22.53 26.10
Year Ending Mar-20 8 31.42 39.55 25.21 29.08
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 30.93 32.76
P/E High - Last 5 Yrs. -- 40.65 45.44
P/E Low - Last 5 Yrs. -- 23.69 24.26
Beta 0.17 0.90 0.89
Price to Sales (TTM) 14.01 3.93 5.74
Price to Book (MRQ) -- 4.88 5.00
Price to Tangible Book (MRQ) -- 5.70 6.57
Price to Cash Flow (TTM) 174.34 22.85 23.29
% Owned Institutions -- 1.23 2.21

Dividends

  Company industry sector
Dividend Yield 1.24 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) 0.00 45.85 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.27 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 5.63
Sales - 5 Yr. Growth Rate -- 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 17.61 20.61
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate -- 15.37 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) -- 2.94 3.03
LT Debt to Equity (MRQ) -- 10.03 12.51
Total Debt to Equity (MRQ) -- 14.07 16.85
Interest Coverage (TTM) -- 35.79 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 54.71 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 18.48 10.68
Operating Margin (TTM) 33.89 14.31 4.32
Operating Margin - 5 Yr. Avg. -- 14.43 6.11
Pre-Tax Margin (TTM) 33.89 14.80 5.18
Pre-Tax Margin - 5 Yr. Avg. -- 14.82 6.51
Net Profit Margin (TTM) 23.12 11.05 1.48
Net Profit Margin - 5 Yr. Avg. -- 11.12 2.78
Effective Tax Rate (TTM) 31.77 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.48 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 952,976,942 860,374,110
Net Income/Employee (TTM) 718,922 112,117,273 101,207,069
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) -- 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.58 11.13
Return on Assets - 5 Yr. Avg. -- 12.95 12.40
Return on Investment (TTM) -- 15.07 14.61
Return on Investment - 5 Yr. Avg. -- 16.90 16.13
Return on Equity (TTM) -- 16.59 16.33
Return on Equity - 5 Yr. Avg. -- 17.97 17.39
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 23
13 Week -6.52 -7.86 99 33
26 Week -11.71 -17.56 99 28
52 Week -17.27 -26.91 99 12
YTD -11.53 -25.96 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 35.85%
# of Holders: 18
Total Shares Held: 30,364,470
3 Mo. Net Change: 10,977,860
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 6
# Reduced Positions: 6
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.